J&J's $5.5B Talc Payout: Ovarian Cancer Claims and Consumer Safety Shift
The settlement highlights decades of health concerns over talc's link to ovarian cancer, prompting J&J to switch to cornstarch and underscoring ongoing consumer trust issues.
Healthcare entity
Erik Haas
Personregulation is the sole category represented across all 1 tracked stories. Erik Haas is most often covered alongside Chris Seeger, which appears in 1 of these 1 story. We currently track 1 Healthcare story that mention Erik Haas, all published on July 28, 2026.
Last mentioned: Jul 28, 2026
Entity pulse
Recent coverage · Erik Haas
1 story
avg impact
0% positive
100% negative
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
What the coverage shows about Erik Haas
regulation is the sole category represented across all 1 tracked stories. Erik Haas is most often covered alongside Chris Seeger, which appears in 1 of these 1 story. We currently track 1 Healthcare story that mention Erik Haas, all published on July 28, 2026. Each carries 3 original sources on average.
- Stories tracked
- 1
- Sources per story
- 3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Erik Haas. Shared-story counts are live from our verified record — not editorial picks.
Stories mentioning Erik Haas 1
Erik Haas is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.